Demant A/S, a hearing healthcare company, develops, manufactures, and sells products and equipment to enhance people's hearing in Europe, North America, the Pacific, Asia, and internationally. Its products include hearing devices and implants; diagnostic instruments; and personal communication systems, such as headsets and solutions for the professional call center and office market, as well as consumer headsets for the gaming and mobile segments. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.
Industry, Sector and Symbol
Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone45-3917-7300
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$2.21 billion
Profitability
Miscellaneous
Employees14,614
Next Earnings Date5/21/2019 (Estimated)
OptionableNot Optionable
DEMANT A S/ADR (OTCMKTS:WILYY) Frequently Asked Questions
What is DEMANT A S/ADR's stock symbol?
DEMANT A S/ADR trades on the OTCMKTS under the ticker symbol "WILYY."
When is DEMANT A S/ADR's next earnings date?
Has DEMANT A S/ADR been receiving favorable news coverage?
Headlines about WILYY stock have trended somewhat negative this week, InfoTrie Sentiment reports. The research group scores the sentiment of news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. DEMANT A S/ADR earned a coverage optimism score of -1.2 on InfoTrie's scale. They also gave news articles about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the next several days.
Who are some of DEMANT A S/ADR's key competitors?
Some companies that are related to DEMANT A S/ADR include Align Technology (ALGN), Zimmer Biomet (ZBH), COLOPLAST A/S/ADR (CLPBY), Smith & Nephew (SNN), Steris (STE), MSA Safety (MSA), Wright Medical Group (WMGI), Avanos Medical (AVNS), Inogen (INGN), Wound Management Technologies (WNDM), Establishment Labs (ESTA), RTI Surgical (RTIX), ConforMIS (CFMS), Invacare (IVC) and Sientra (SIEN).
What other stocks do shareholders of DEMANT A S/ADR own?
Who are DEMANT A S/ADR's key executives?
DEMANT A S/ADR's management team includes the folowing people:
- Mr. Søren Nielsen, CEO, Pres & Member of Exec. Board (Age 49)
- Mr. René Schneider, CFO & Member of Exec. Board (Age 46)
- Mr. Søren Bergholt Andersson, VP of Investor Relations (Age 42)
- Ms. Trine Kromann-Mikkelsen, VP of Corp. Communication & Relations
- Mr. Jes Olsen, Pres of Oticon Medical
How do I buy shares of DEMANT A S/ADR?
Shares of WILYY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is DEMANT A S/ADR's stock price today?
One share of WILYY stock can currently be purchased for approximately $16.95.
How big of a company is DEMANT A S/ADR?
DEMANT A S/ADR has a market capitalization of $8.31 billion and generates $2.21 billion in revenue each year. The company earns $288.76 million in net income (profit) each year or $0.58 on an earnings per share basis. DEMANT A S/ADR employs 14,614 workers across the globe.
What is DEMANT A S/ADR's official website?
How can I contact DEMANT A S/ADR?
DEMANT A S/ADR's mailing address is Kongebakken 9, Smorum G7, 2765. The company can be reached via phone at 45-3917-7300 or via email at [email protected]
MarketBeat Community Rating for DEMANT A S/ADR (OTCMKTS WILYY)
MarketBeat's community ratings are surveys of what our community members think about DEMANT A S/ADR and other stocks. Vote "Outperform" if you believe WILYY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WILYY will underperform the S&P 500 over the long term. You may vote once every thirty days.
